Published in Nurs Res on June 23, 1983
Genetic control of the cell division cycle in yeast. Science (1974) 13.83
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41
A p53-dependent mouse spindle checkpoint. Science (1995) 4.01
Regulation of mating in the cell cycle of Saccharomyces cerevisiae. J Cell Biol (1977) 3.68
Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet (1999) 3.30
17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci U S A (1996) 2.53
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol (2001) 2.21
Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology (1987) 2.15
Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res (2000) 2.13
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res (2001) 2.06
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med (2000) 2.05
Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology (1992) 2.03
Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol (1986) 1.91
Loss of heterozygosity analysis using whole genome amplification, cell sorting, and fluorescence-based PCR. Genome Res (1999) 1.90
Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest (1989) 1.83
Comparative genomic analysis of tumors: detection of DNA losses and amplification. Proc Natl Acad Sci U S A (1995) 1.75
p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas. Cancer Res (1997) 1.67
Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res (1992) 1.65
p53-mutant clones and field effects in Barrett's esophagus. Cancer Res (1999) 1.61
Progressive region-specific de novo methylation of the p16 CpG island in primary human mammary epithelial cell strains during escape from M(0) growth arrest. Mol Cell Biol (1999) 1.56
Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci U S A (1992) 1.56
Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc Natl Acad Sci U S A (1991) 1.53
17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res (1994) 1.52
Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas. Cancer Res (1994) 1.49
Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene (1996) 1.46
Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst (1999) 1.44
p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology (1994) 1.43
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc Natl Acad Sci U S A (1993) 1.40
17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res (1991) 1.39
Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene (1996) 1.32
Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus. Am J Gastroenterol (2000) 1.25
Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay. Histopathology (1990) 1.24
Genotypic analysis of multiple loci in somatic cells by whole genome amplification. Nucleic Acids Res (1995) 1.24
Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology (1998) 1.24
Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res (1996) 1.14
Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology (1991) 1.11
Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol (1988) 1.10
High-quality RNA and DNA from flow cytometrically sorted human epithelial cells and tissues. Biotechniques (2002) 1.08
The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer (1994) 1.05
Multiple keratoacanthomata. A unique case and review of the current classification. Acta Derm Venereol (1978) 1.04
Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. Cancer Res (1991) 0.99
Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study. Lab Invest (1989) 0.99
Impact of composting strategies on the treatment of soils contaminated with organic pollutants. Environ Pollut (2001) 0.99
Barrett's esophagus and adenocarcinoma. Annu Rev Med (1987) 0.99
Endoscopic biopsy technique for acquiring larger mucosal samples. Gastrointest Endosc (1991) 0.97
Barrett's esophagus: a model of human neoplastic progression. Cold Spring Harb Symp Quant Biol (1994) 0.97
Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium. Gastroenterology (1989) 0.97
Persistent clonal areas and clonal expansion in Barrett's esophagus. Cancer Res (1992) 0.97
Biomarkers in Barrett esophagus. Mayo Clin Proc (2001) 0.97
Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus. Nutr Cancer (2000) 0.94
Application of a luminescence-based biosensor for assessing naphthalene biodegradation in soils from a manufactured gas plant. Environ Pollut (2009) 0.90
p53 and neoplastic progression in Barrett's esophagus. Am J Gastroenterol (2001) 0.89
Study of tinea capitis in Philadelphia using case and control groups. Public Health Rep (1968) 0.87
Inactivation of p53 and the development of tetraploidy in the elastase-SV40 T antigen transgenic mouse pancreas. Pancreas (1995) 0.86
Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium. Dig Dis Sci (1989) 0.86
Actinic granuloma in association with giant cell arteritis: are both caused by sunlight? Pathology (1997) 0.86
Flow-cytometric DNA content analysis of esophageal squamous cell carcinomas. Gastroenterology (1991) 0.85
Barrett's esophagus: the biology of neoplastic progression. Gastroenterol Clin Biol (1994) 0.85
Loss of heterozygosity in childhood de novo acute myelogenous leukemia. Blood (2001) 0.83
Oxytetracycline in the treatment of ocular rosacea: a double-blind trial. Br J Ophthalmol (1982) 0.82
Unfamiliar aspects of familial polyposis coli. Am J Surg (1986) 0.78
Exophiala werneckii causing tinea nigra in Scotland. Br J Dermatol (1998) 0.78
Comparison of selected non-exhaustive extraction techniques to assess PAH availability in dissimilar soils. Chemosphere (2005) 0.75
A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinoma. IEEE Trans Biomed Eng (2001) 0.75
The influence of a NAPL on the loss and biodegradation of 14C-phenanthrene residues in two dissimilar soils. Chemosphere (2007) 0.75
Re: 'Competence of Nursing Graduates in Technical, Communicative, and Administrative Skills'. Nurs Res (1979) 0.75
Letter: Tetracyclines in gonorrhea therapy. N Engl J Med (1976) 0.75
New record for Aedes thelcter in Arizona. J Am Mosq Control Assoc (1990) 0.75